O46.093 Antepartum hemorrhage with other coagulation defect, third trimester

Name of the Condition

• Antepartum Hemorrhage with Other Coagulation Defect, Third Trimester

Summary

Antepartum hemorrhage refers to bleeding from the genital tract during pregnancy, typically after 20 weeks of gestation. When associated with another coagulation defect in the third trimester, the bleeding may be exacerbated by underlying issues with blood clotting, which can complicate management and increase risks to both the mother and fetus. The term "other" indicates a coagulation defect that is not specified as afibrinogenemia or another defined type, and the third trimester specifies the timing of the condition.

Causes

The coagulation defect in antepartum hemorrhage may arise from preexisting conditions such as inherited clotting disorders, acquired deficiencies (e.g., vitamin K deficiency), or complications like disseminated intravascular coagulation (DIC). These defects can be triggered by severe bleeding, infection, or other systemic issues that disrupt normal clotting mechanisms. Pregnancy-related complications like placental abruption or previa may also contribute to or worsen the coagulation abnormality.

Risk Factors

• Preexisting clotting disorders (e.g., hemophilia, von Willebrand disease)
• Severe infection or sepsis
• Placental abruption or previa
• Trauma or injury to the abdomen
• Multiple pregnancies
• History of bleeding disorders or previous hemorrhage
• Use of anticoagulant medications

Symptoms

• Vaginal bleeding (ranging from spotting to heavy flow)
• Excessive bruising or prolonged bleeding from minor injuries
• Fatigue or weakness (due to blood loss)
• Signs of coagulation issues, such as petechiae or uncontrolled bleeding
• Abdominal pain or cramping
• Rapid heart rate or low blood pressure in severe cases

Diagnosis

Diagnosis involves assessing the bleeding pattern and evaluating coagulation status through laboratory tests (e.g., PT, aPTT, fibrinogen levels). Imaging studies like ultrasound may be used to identify obstetric causes (e.g., placental abruption). Clinical history, including prior bleeding disorders or medication use, is also considered.

Treatment Options

Management focuses on stabilizing the mother and addressing the underlying cause. This may include blood transfusions, medications to control bleeding, and delivery if the fetus is viable. Coagulation defects may require specific treatments like vitamin K supplementation or replacement therapies. Close monitoring of both mother and fetus is essential.

Prognosis and Follow-Up

Prognosis depends on the severity of bleeding, the underlying coagulation defect, and timely intervention. Complications can include maternal or fetal distress, preterm birth, or hemorrhagic shock. Follow-up involves monitoring for recurrent bleeding, assessing coagulation function, and managing any long-term effects of the condition or its treatment.

Complications

• Maternal hemorrhagic shock
• Fetal distress or preterm birth
• Disseminated intravascular coagulation (DIC)
• Anemia or other blood-related issues
• Increased risk of future bleeding episodes

Lifestyle & Prevention

• Avoid activities with a high risk of abdominal trauma.
• Manage preexisting conditions (e.g., clotting disorders) with medical guidance.
• Attend regular prenatal care to monitor for complications.
• Report any unusual bleeding or symptoms promptly to healthcare providers.

When to Seek Professional Help

Seek immediate medical attention for heavy vaginal bleeding, severe abdominal pain, dizziness, or signs of shock (e.g., rapid heart rate, low blood pressure). Prompt evaluation is critical to address bleeding and coagulation issues effectively.

Tips for Medical Coders

Document the timing (third trimester) and the specific coagulation defect (classified as "other") to support accurate coding. Ensure clinical documentation clarifies the relationship between the hemorrhage and the coagulation defect, as well as any contributing obstetric or systemic factors.